about
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab.Immunology proves a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology: IUPHAR Review 23.Room for more IL-6 blockade? Sarilumab for the treatment of rheumatoid arthritis.Targeting IL-17 in autoimmunity and inflammation.Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis.Treatment of Moderate to Severe Psoriasis With High-Dose (450-mg) Secukinumab: Case Reports of Off-Label Use.Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.
P2860
Q37712237-5026AA8E-A2C6-43E2-9FD5-F3233A2CF385Q38744431-965BBC05-DD6E-4B42-8694-462F4C01AC46Q38910201-8CE184FD-AE7B-4551-AE1D-453C3F76CE8DQ38941407-B7F4EAB1-E9F9-4995-A847-BC74AEF7559FQ39033726-31E96A90-E151-438E-9477-179CE2A0F429Q47689590-D90EA05A-4A42-4321-9ADD-65BF0F91C19DQ55031102-7370E5CD-1061-4BDA-901C-83AB6EA783EE
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Secukinumab for treating plaque psoriasis.
@en
type
label
Secukinumab for treating plaque psoriasis.
@en
prefLabel
Secukinumab for treating plaque psoriasis.
@en
P2860
P1476
Secukinumab for treating plaque psoriasis.
@en
P2093
Alice Gottlieb
Brooke Rothstein
P2860
P304
P356
10.1517/14712598.2016.1121986
P407
P577
2015-11-17T00:00:00Z